Axsome Therapeutics (AXSM) Asset Utilization Ratio (2023 - 2025)
Historic Asset Utilization Ratio for Axsome Therapeutics (AXSM) over the last 4 years, with Q3 2025 value amounting to 0.86.
- Axsome Therapeutics' Asset Utilization Ratio rose 4057.59% to 0.86 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.86, marking a year-over-year increase of 4057.59%. This contributed to the annual value of 0.67 for FY2024, which is 1332.67% up from last year.
- As of Q3 2025, Axsome Therapeutics' Asset Utilization Ratio stood at 0.86, which was up 4057.59% from 0.8 recorded in Q2 2025.
- Over the past 5 years, Axsome Therapeutics' Asset Utilization Ratio peaked at 0.86 during Q3 2025, and registered a low of 0.15 during Q4 2022.
- In the last 4 years, Axsome Therapeutics' Asset Utilization Ratio had a median value of 0.49 in 2023 and averaged 0.53.
- In the last 5 years, Axsome Therapeutics' Asset Utilization Ratio soared by 20491.35% in 2023 and then soared by 1031.49% in 2024.
- Quarter analysis of 4 years shows Axsome Therapeutics' Asset Utilization Ratio stood at 0.15 in 2022, then soared by 204.91% to 0.46 in 2023, then soared by 49.99% to 0.68 in 2024, then increased by 25.61% to 0.86 in 2025.
- Its Asset Utilization Ratio was 0.86 in Q3 2025, compared to 0.8 in Q2 2025 and 0.74 in Q1 2025.